Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
THC
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
zacks.com
10 hours ago
zacks.com
10 hours ago
zacks.com
10 hours ago
zacks.com
10 hours ago
zacks.com
18 hours ago
Quote Panel
Key Metrics
Earnings Growth
YoY
Current
Estimates
Q3.23
N/A
1.44
vs 1.44
Q4.23
+37%
2.68
vs 1.96
Q1.24
+127%
3.22
vs 1.42
Q2.24
+60%
2.31
vs 1.44
Q3.24
+103%
2.93
vs 1.44
Q4.24
+28%
3.44
vs 2.68
Q1.25
+35%
4.36
vs 3.22
Q2.25
+74%
4.02
vs 2.31
Q3.25
+12%
3.3
vs 2.93
Q4.25
+19%
4.08
vs 3.44
Sales Growth
YoY
Current
Estimates
Q3.23
+6%
5.1B vs 4.8B
Q4.23
+8%
5.4B vs 5B
Q1.24
+7%
5.4B vs 5B
Q2.24
+0%
5.1B vs 5.1B
Q3.24
+1%
5.1B vs 5.1B
Q4.24
-6%
5.1B vs 5.4B
Q1.25
-3%
5.2B vs 5.4B
Q2.25
+3%
5.3B vs 5.1B
Q3.25
+3%
5.3B vs 5.1B
Q4.25
+6%
5.4B vs 5.1B
Return on Equity
QoQ
Q1.23
+24%
0.24
vs 0.24
Q2.23
+9%
0.09
vs 0.24
Q3.23
+7%
0.07
vs 0.09
Q4.23
+15%
0.15
vs 0.07
Q1.24
+62%
0.62
vs 0.15
Q2.24
+7%
0.07
vs 0.62
Q3.24
+12%
0.12
vs 0.07
Q4.24
+8%
0.08
vs 0.12
Q1.25
+10%
0.1
vs 0.08
Q2.25
+8%
0.08
vs 0.1
Institutionnal Ownership
QoQ
Q4.22
397
397
vs 385
3%
Q1.23
393
393
vs 397
-1%
Q2.23
451
451
vs 393
15%
Q3.23
445
445
vs 451
-1%
Q4.23
469
469
vs 445
5%
Q1.24
499
499
vs 469
6%
Q2.24
571
571
vs 499
14%
Q3.24
642
642
vs 571
12%
Q4.24
630
630
vs 642
-2%
Q1.25
598
598
vs 630
-5%
Relative Strength
THC
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
2026-Revenue
2026-EPS
2026-EBITDA
Analyst rating
Price Target
205.00(19.65%)
Number of analyst
1
Last analyst upgrade/downgrade
Wolfe Research
downgradePrevious: Outperform
2025-07-28
Now: Peer Perform
Wells Fargo
upgradePrevious: Buy
2025-05-29
Now: Overweight
Morgan Stanley
initialisePrevious: Not converted
2025-03-26
Now: Overweight
Goldman Sachs
downgradePrevious: Buy
2024-12-16
Now: Neutral